TOP NEWS

Quanticel Pharmaceuticals Acquired By Celgene

San Diego- and San Francisco-based Quanticel Pharmaceuticals has been acquired Celgene, in a deal worth $100M in cash plus up to $385M in earn out. Celgene said the deal gives it access to Quanticel's proprietary platform for the single-cell genomic analysis of human cancer, to help advance Celgene's pipeline of cancer therapies. Quanticel had been led by Steve Kaldor, and was venture backed by Versant Ventures.


LATEST HEADLINES

More Headlines

BROWSE ISSUES